AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Biocon to invest Rup 450 crores on insulin programmes.

Chemical Business Newsbase

| April 22, 2011 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Pharma firm Biocon proposes to invest Rup 450 crores on insulin programmes by 2014/2015 besides Rup 100 crores on a dedicated research and development facility …

Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily